Richardson and Anderson, both teachers of medicine at Harvard Medical School, compile novel therapies being developed to target specific molecular pathways involved in the oncogenesis of myeloma. Chapters cover epidemiology and molecular pathogenesis, mechanisms of drug resistance, thalidomide treatment, bone disease, high-dose chemotherapy, supportive care, and novel biological therapies. The book will be of interest to specialist hematologists and oncologists and other healthcare providers. Annotation ©2004 Book News, Inc., Portland, OR (booknews.com)
"synopsis" may belong to another edition of this title.
KENNETH C. ANDERSON is the Kraft Family Professor of Medicine, Harvard Medical School, Boston, Massachusetts; Director, Jerome Lipper Multiple Myeloma Center; and Chief, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts. A member of the Translational Research Working Group of the National Cancer Institute and the American Society of Clinical Oncology Translational Research Task Force, Dr. Anderson is a member of numerous societies, including the American Society for Blood and Marrow Transplantation and the American Association for Cancer Research, among other organizations. Dr. Anderson is the author, coauthor, or editor of a vast array of journal articles, book chapters, and invited lectures. Dr. Anderson received the M.D. degree from the Johns Hopkins University School of Medicine, Baltimore, Maryland.
IRENE M. GHOBRIAL is on Active Staff, Dana-Farber Cancer Institute, Boston, Massachusetts. The recipient of the ASCO Career Development Award (ASCO-CDA) (2006), Dr. Ghobrial is a member of the American Society of Hematology and the American Society of Clinical Oncology, among other organizations. Dr. Ghobrial is the author, coauthor, or editor of numerous professional publications, and received the M.D. degree from Cairo University, Egypt.
"About this title" may belong to another edition of this title.
Shipping:
US$ 4.49
Within U.S.A.
Shipping:
US$ 33.29
From United Kingdom to U.S.A.
Seller: Adagio Books, Longmont, CO, U.S.A.
Soft cover. Condition: Very Good. In very good, unread condition with minor shelfwear to cover. Provides a description of the basic molecular pathways of myeloma pathogenesis that form the basis of new target-based therapies. Size: 5 1/2 x 8 1/2. Seller Inventory # 9229-7
Quantity: 1 available
Seller: Bookbot, Prague, Czech Republic
Condition: Fine. Seller Inventory # ddefeefa-aa7e-4ab7-9539-a18dade233d9
Quantity: 1 available
Seller: WeBuyBooks, Rossendale, LANCS, United Kingdom
Condition: Good. Most items will be dispatched the same or the next working day. Previous owners name. Seller Inventory # wbb0023323776
Quantity: 1 available
Seller: dsmbooks, Liverpool, United Kingdom
Paperback. Condition: New. New. book. Seller Inventory # D8S0-3-M-190134648X-6
Quantity: 1 available